Castro-Martínez JC, Ortiz-Castellanos AF, Mojica-Ospina LE, De la Espriella-Guerrero RA

Language: Spanish
References: 19
Page: 12-16
PDF size: 681.24 Kb.

ABSTRACT

No abstract.

REFERENCES

1. Richards F, Curtice M. Mania in late life. Adv Psychiatr Treat. 2011;17:357-64.

2. Dols A, Beekman A. Older age bipolar disorder. Psychiatr Clin NorthAm. 2018;41(1):95-110. doi: 10.1016/j.psc.2017.10.008

3. Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med.2018;378(9):840-851. doi: 10.1056/NEJMra1708712

4. Grativvol RS, Cavalcante WCP, Castro LHM, Nitrini R, Simabukuro MM.Updates in the diagnosis and treatment of paraneoplastic neurologic syndromes.Curr Oncol Rep. 2018;20(11):92. doi: 10.1007/s11912-018-0721-y

5. Graus F, Vogrig A, Muñiz-Castrillo S, Antoine JG, Desestret V, DubeyD, et al. Updated diagnostic criteria for paraneoplastic neurologicsyndromes. Neurol Neuroimmunol Neuroinflamm. 2021;8(4):e1014.doi: 10.1212/NXI.0000000000001014

6. Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F,Leypoldt F, et al. An update on anti-NMDA receptor encephalitis forneurologists and psychiatrists: mechanisms and models. Lancet Neurol.2019;18(11):1045-57. doi: 10.1016/S1474-4422(19)30244-3

7. Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al.A clinical approach to diagnosis of autoimmune encephalitis. LancetNeurol. 2016;15(4):391-404. doi: 10.1016/S1474-4422(15)00401-9

8. Pollak TA, Lennox BR, Müller S, Benros ME, Prüss H, Tebartz van ElstL, et al. Autoimmune psychosis: an international consensus on anapproach to the diagnosis and management of psychosis of suspectedautoimmune origin. Lancet Psychiatry. 2020;7(1):93-108. doi: 10.1016/S2215-0366(19)30290-1

9. Graus F, Dalmau J. Autoimmune encephalitis or autoimmune psychosis?Eur Neuropsychopharmacol. 2021; 50:112-4. doi: 10.1016/j.euroneuro.2021.05.004

10. Restrepo-Martínez M, Espinola-Nadurille M, López-Hernández JC,Martínez V, Téllez-Martínez JA, Bustamante-Gómez PA, et al. Aspectosneuropsiquiátricos de la encefalitis por anticuerpos contra el receptorNMDA. Rev Alerg Mex. 2021; 68(4):251-63. doi: 10.29262/ram.v68i4.953

11. Seery N, Butzkueven H, O’Brien TJ, Monif M. Rare antibody-mediatedand seronegative autoimmune encephalitis: An update. Autoimmun Rev.2022;21(7):103118. doi: 10.1016/j.autrev.2022.103118

12. Lee WJ, Lee HS, Kim DY, Lee HS, Moon J, Park KI, et al. Seronegativeautoimmune encephalitis: clinical characteristics and factors associatedwith outcomes. Brain. 2022;145(10):3509-21. doi: 10.1093/brain/awac166

13. Martinez I, Šulentić V, Nanković S, Žarković K, Dobec-Gorenak D.Unpredictable relapses in seronegative autoimmune encephalitis. NeurolSci. 2021;42(12):5391-3. doi: 10.1007/s10072-021-05637-w

14. Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, etal. Autoimmune encephalitis: proposed best practice recommendationsfor diagnosis and acute management. J Neurol Neurosurg Psychiatry.2021;92(7):757-68. doi: 10.1136/jnnp-2020-325300

15. Martin A, Young C, Leckman JF, Mukonoweshuro C, Rosenheck R, LeslieD. Age effects on antidepressant-induced manic conversion. Arch PediatrAdolesc Med. 2004;158(8):773-80. doi: 10.1001/archpedi.158.8.773

16. Tang SW, Tang WH, Leonard BE. Treatment-induced mood switchingin affective disorders. Acta Neuropsychiatr. 2022;34(2):55-68. doi:10.1017/neu.2021.47

17. Wijeratne C, Malhi GS. Vascular mania: an old concept in dangerof sclerosing? A clinical overview. Acta Psychiatr Scand Suppl.2007;(434):35-40. doi: 10.1111/j.1600-0447.2007.01057.x

18. Cassidy F, Carroll BJ. Vascular risk factors in late onset mania. PsycholMed. 2002;32(2):359-62. doi: 10.1017/s0033291701004718

19. Toro J, Cuellar-Giraldo D, Duque A, Minota K, Patiño J, GarcíaM. Seronegative paraneoplastic limbic encephalitis associated withthymoma. Cogn Behav Neurol. 2017;30(3):125-8. doi: 10.1097/WNN.0000000000000134